CN Stock MarketDetailed Quotes

688302 Hinova Pharmaceuticals Inc.

Watchlist

45.69
-2.31-4.81%

Market Closed May 12 15:00 CST

4.52BMarket Cap-24.54P/E (TTM)

Hinova Pharmaceuticals Inc. Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Total operating revenue

366.84K

109.73K

1.65M

Operating revenue

--0

--366.84K

--109.73K

--0

--1.65M

Total operating cost

-29.79%36.73M

-33.00%217.54M

-36.06%167.13M

-39.64%109.81M

-36.68%52.31M

-5.07%324.7M

4.92%261.39M

10.95%181.91M

-12.37%82.61M

-1.32%342.04M

Operating cost

----

--335.92K

--96.52K

----

--766.47K

Operating tax surcharges

-8.83%86.85K

-1.40%411.28K

36.79%335.46K

18.43%231.72K

322.27%95.26K

19.61%417.13K

96.23%245.24K

57.20%195.66K

41.81%22.56K

437.50%348.73K

Operating expense

28.33%3.9M

35.82%11.35M

46.98%8.06M

280.08%5.77M

412.66%3.04M

--8.36M

--5.48M

--1.52M

--593.05K

----

Administration expense

0.99%10.12M

-47.09%42.14M

-46.55%31.41M

-46.18%21.37M

-47.40%10.02M

-17.93%79.64M

-16.58%58.77M

-13.23%39.7M

-19.51%19.06M

20.87%97.04M

Financial expense

23.92%-2.15M

10.49%-10.73M

38.38%-6.08M

25.36%-5.58M

-300.17%-2.82M

-60.40%-11.99M

-10.60%-9.86M

-108.61%-7.48M

-228.27%-705.81K

-661.42%-7.48M

-Interest expense (Financial expense)

41.05%205.52K

-64.60%526.61K

-68.59%386.14K

-66.20%267.49K

-57.95%145.71K

-62.09%1.49M

-58.68%1.23M

-63.59%791.49K

-67.51%346.52K

53.45%3.92M

-Interest Income (Financial expense)

17.65%-2.46M

17.51%-10.01M

11.72%-7.71M

-6.75%-5.53M

-29.25%-2.98M

-212.81%-12.14M

-226.04%-8.73M

-203.21%-5.18M

-190.56%-2.31M

-14.01%-3.88M

Research and development

-41.00%24.77M

-29.90%174.03M

-35.52%133.31M

-40.58%87.92M

-34.05%41.98M

-1.23%248.27M

10.28%206.76M

21.62%147.98M

-9.12%63.64M

-5.12%251.37M

Credit Impairment Loss

-78.50%-731.4K

-3.05%-324.71K

-2.19%-313.07K

4.27%-292.26K

-15,364.40%-409.76K

-145.61%-315.09K

-184.92%-306.37K

-193.78%-305.28K

94.96%-2.65K

-82.05%-128.29K

Other net revenue

Fair value change income

18.74%1.54M

-52.54%3.96M

-38.97%3.48M

-49.94%2.23M

-59.58%1.29M

-18.69%8.35M

-36.91%5.7M

188.40%4.46M

--3.2M

784.64%10.27M

Invest income

-36.06%1.92M

-44.52%9.14M

-48.36%6.94M

-44.87%5.07M

-11.32%3M

-11.49%16.48M

22.90%13.45M

0.16%9.2M

-12.14%3.39M

-20.97%18.62M

Other revenue

57.50%1.9M

-18.77%4.91M

-36.94%2.85M

-32.37%2.28M

84.16%1.21M

-40.56%6.04M

-33.44%4.52M

-38.75%3.38M

-81.87%656.06K

-44.86%10.17M

Operating profit

32.01%-32.1M

32.18%-199.48M

35.28%-154.06M

39.22%-100.4M

37.36%-47.21M

2.43%-294.13M

-6.99%-238.03M

-11.75%-165.18M

13.22%-75.37M

1.54%-301.46M

Add:Non operating Income

----

--110

--1.75

--1.43

----

Less:Non operating expense

----

-58.93%2.07K

207.38%2.07K

218.68%1.71K

91.30%1.03K

-90.24%5.05K

-98.69%674.39

-98.94%537.65

1,576.05%51.71K

Total profit

32.01%-32.1M

32.18%-199.48M

35.28%-154.06M

39.22%-100.4M

37.36%-47.21M

2.45%-294.14M

-6.96%-238.03M

-11.71%-165.18M

13.27%-75.37M

1.52%-301.51M

Less:Income tax cost

--2.01K

-35.93%12.23K

-50.11%8.89K

-49.52%8.88K

----

--19.09K

--17.81K

--17.59K

----

Net profit

32.01%-32.1M

32.18%-199.5M

35.28%-154.07M

39.22%-100.41M

37.36%-47.21M

2.44%-294.16M

-6.97%-238.05M

-11.72%-165.2M

13.27%-75.37M

1.52%-301.51M

Net profit from continuing operation

32.01%-32.1M

32.18%-199.5M

35.28%-154.07M

39.22%-100.41M

37.36%-47.21M

2.44%-294.16M

-6.97%-238.05M

-11.72%-165.2M

13.27%-75.37M

1.52%-301.51M

Net profit of parent company owners

32.01%-32.1M

32.18%-199.5M

35.28%-154.07M

39.22%-100.41M

37.36%-47.21M

2.44%-294.16M

-6.97%-238.05M

-11.72%-165.2M

13.27%-75.37M

1.52%-301.51M

Earning per share

Basic earning per share

33.33%-0.32

32.32%-2.01

35.00%-1.56

39.52%-1.01

36.84%-0.48

10.54%-2.97

3.23%-2.4

4.02%-1.67

35.04%-0.76

19.42%-3.32

Other composite income

-147.43%-12.51K

-441.32%-139.27K

-139.26%-50.94K

-65.76%52.61K

164.42%26.38K

-112.33%-25.73K

-11.27%129.75K

-52.49%153.65K

-307.19%-40.95K

825.84%208.63K

Other composite income of parent company owners

-147.43%-12.51K

-441.32%-139.27K

-139.26%-50.94K

-65.76%52.61K

164.42%26.38K

-112.33%-25.73K

-11.27%129.75K

-52.49%153.65K

-307.19%-40.95K

825.84%208.63K

Total composite income

31.94%-32.11M

32.14%-199.64M

35.22%-154.12M

39.19%-100.36M

37.42%-47.19M

2.36%-294.18M

-6.98%-237.92M

-11.86%-165.05M

13.23%-75.41M

1.60%-301.31M

Total composite income of parent company owners

31.94%-32.11M

32.14%-199.64M

35.22%-154.12M

39.19%-100.36M

37.42%-47.19M

2.36%-294.18M

-6.98%-237.92M

-11.86%-165.05M

13.23%-75.41M

1.60%-301.31M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Deloitte Huayong Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Total operating revenue	0	366.84K	109.73K	109.73K	0	0	0	0	0	1.65M
Operating revenue	--0	--366.84K	--109.73K	--109.73K	--0	--0	--0	--0	--0	--1.65M
Total operating cost	-29.79%36.73M	-33.00%217.54M	-36.06%167.13M	-39.64%109.81M	-36.68%52.31M	-5.07%324.7M	4.92%261.39M	10.95%181.91M	-12.37%82.61M	-1.32%342.04M
Operating cost	----	--335.92K	--96.52K	--96.52K	----	----	----	----	----	--766.47K
Operating tax surcharges	-8.83%86.85K	-1.40%411.28K	36.79%335.46K	18.43%231.72K	322.27%95.26K	19.61%417.13K	96.23%245.24K	57.20%195.66K	41.81%22.56K	437.50%348.73K
Operating expense	28.33%3.9M	35.82%11.35M	46.98%8.06M	280.08%5.77M	412.66%3.04M	--8.36M	--5.48M	--1.52M	--593.05K	----
Administration expense	0.99%10.12M	-47.09%42.14M	-46.55%31.41M	-46.18%21.37M	-47.40%10.02M	-17.93%79.64M	-16.58%58.77M	-13.23%39.7M	-19.51%19.06M	20.87%97.04M
Financial expense	23.92%-2.15M	10.49%-10.73M	38.38%-6.08M	25.36%-5.58M	-300.17%-2.82M	-60.40%-11.99M	-10.60%-9.86M	-108.61%-7.48M	-228.27%-705.81K	-661.42%-7.48M
-Interest expense (Financial expense)	41.05%205.52K	-64.60%526.61K	-68.59%386.14K	-66.20%267.49K	-57.95%145.71K	-62.09%1.49M	-58.68%1.23M	-63.59%791.49K	-67.51%346.52K	53.45%3.92M
-Interest Income (Financial expense)	17.65%-2.46M	17.51%-10.01M	11.72%-7.71M	-6.75%-5.53M	-29.25%-2.98M	-212.81%-12.14M	-226.04%-8.73M	-203.21%-5.18M	-190.56%-2.31M	-14.01%-3.88M
Research and development	-41.00%24.77M	-29.90%174.03M	-35.52%133.31M	-40.58%87.92M	-34.05%41.98M	-1.23%248.27M	10.28%206.76M	21.62%147.98M	-9.12%63.64M	-5.12%251.37M
Credit Impairment Loss	-78.50%-731.4K	-3.05%-324.71K	-2.19%-313.07K	4.27%-292.26K	-15,364.40%-409.76K	-145.61%-315.09K	-184.92%-306.37K	-193.78%-305.28K	94.96%-2.65K	-82.05%-128.29K
Other net revenue
Fair value change income	18.74%1.54M	-52.54%3.96M	-38.97%3.48M	-49.94%2.23M	-59.58%1.29M	-18.69%8.35M	-36.91%5.7M	188.40%4.46M	--3.2M	784.64%10.27M
Invest income	-36.06%1.92M	-44.52%9.14M	-48.36%6.94M	-44.87%5.07M	-11.32%3M	-11.49%16.48M	22.90%13.45M	0.16%9.2M	-12.14%3.39M	-20.97%18.62M
Other revenue	57.50%1.9M	-18.77%4.91M	-36.94%2.85M	-32.37%2.28M	84.16%1.21M	-40.56%6.04M	-33.44%4.52M	-38.75%3.38M	-81.87%656.06K	-44.86%10.17M
Operating profit	32.01%-32.1M	32.18%-199.48M	35.28%-154.06M	39.22%-100.4M	37.36%-47.21M	2.43%-294.13M	-6.99%-238.03M	-11.75%-165.18M	13.22%-75.37M	1.54%-301.46M
Add:Non operating Income	----	--110	--1.75	--1.43	----	----	----	----	----	----
Less:Non operating expense	----	-58.93%2.07K	207.38%2.07K	218.68%1.71K	91.30%1.03K	-90.24%5.05K	-98.69%674.39	-98.94%537.65	-98.94%537.65	1,576.05%51.71K
Total profit	32.01%-32.1M	32.18%-199.48M	35.28%-154.06M	39.22%-100.4M	37.36%-47.21M	2.45%-294.14M	-6.96%-238.03M	-11.71%-165.18M	13.27%-75.37M	1.52%-301.51M
Less:Income tax cost	--2.01K	-35.93%12.23K	-50.11%8.89K	-49.52%8.88K	----	--19.09K	--17.81K	--17.59K	----	----
Net profit	32.01%-32.1M	32.18%-199.5M	35.28%-154.07M	39.22%-100.41M	37.36%-47.21M	2.44%-294.16M	-6.97%-238.05M	-11.72%-165.2M	13.27%-75.37M	1.52%-301.51M
Net profit from continuing operation	32.01%-32.1M	32.18%-199.5M	35.28%-154.07M	39.22%-100.41M	37.36%-47.21M	2.44%-294.16M	-6.97%-238.05M	-11.72%-165.2M	13.27%-75.37M	1.52%-301.51M
Net profit of parent company owners	32.01%-32.1M	32.18%-199.5M	35.28%-154.07M	39.22%-100.41M	37.36%-47.21M	2.44%-294.16M	-6.97%-238.05M	-11.72%-165.2M	13.27%-75.37M	1.52%-301.51M
Earning per share
Basic earning per share	33.33%-0.32	32.32%-2.01	35.00%-1.56	39.52%-1.01	36.84%-0.48	10.54%-2.97	3.23%-2.4	4.02%-1.67	35.04%-0.76	19.42%-3.32
Other composite income	-147.43%-12.51K	-441.32%-139.27K	-139.26%-50.94K	-65.76%52.61K	164.42%26.38K	-112.33%-25.73K	-11.27%129.75K	-52.49%153.65K	-307.19%-40.95K	825.84%208.63K
Other composite income of parent company owners	-147.43%-12.51K	-441.32%-139.27K	-139.26%-50.94K	-65.76%52.61K	164.42%26.38K	-112.33%-25.73K	-11.27%129.75K	-52.49%153.65K	-307.19%-40.95K	825.84%208.63K
Total composite income	31.94%-32.11M	32.14%-199.64M	35.22%-154.12M	39.19%-100.36M	37.42%-47.19M	2.36%-294.18M	-6.98%-237.92M	-11.86%-165.05M	13.23%-75.41M	1.60%-301.31M
Total composite income of parent company owners	31.94%-32.11M	32.14%-199.64M	35.22%-154.12M	39.19%-100.36M	37.42%-47.19M	2.36%-294.18M	-6.98%-237.92M	-11.86%-165.05M	13.23%-75.41M	1.60%-301.31M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	--	--	--	--	Deloitte Huayong Certified Public Accountants (Special General Partnership)	--	--	--	Deloitte Huayong Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

688302 Hinova Pharmaceuticals Inc.

Hinova Pharmaceuticals Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course